Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

J&J receives CHMP positive opinion for Akeega to treat patients with metastatic hormone-sensitive prostate cancer with BRCA1/2 mutations: Beerse, Belgium Monday, February 2, 2026, ...

Prostate cancer (PCa) remains a significant global health challenge, with rising morbidity rates and poor prognosis associated with advanced stages ...

AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen a ...

Investigators trialed injection of an immune-stimulating substance (poly-ICLC) into the prostate gland using MRI-ultrasound fusion technology in patients scheduled to undergo radical prostatectomy.

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

The American Cancer Society's annual cancer statistics report reveals that for the first time, 70% of people diagnosed with ...

Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients ...

Prostate cancer has overtaken breast cancer to become the most common form of the disease in the UK for the first time.

Rebecca Siegel highlights alarming cancer disparities among American Indian, Alaska Native, and Black populations, ...

Experts project the diagnosis of over 300,000 prostate cancer cases in the United States in 2006, along with over 30,000 ...

Cancer charity highlights apparent ‘postcode lottery’ of testing and diagnoses across different regions seen in study ...